2019-09-05 09:26:00 Thu ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America. First, the Chinese Xi administration would never lose legitimacy due to subpar 5.5%-to-6.3% real GDP economic growth. China retains more fiscal and monetary policy levers than global growth headwinds. Second, Chinese hawkish hardliners remain patient and methodical when they deal with external wildcards. These external wildcards include U.S. partisanship and economic policy uncertainty, Brexit trade and capital exodus, and diplomatic outrage in the South China Sea.
Third, the 5G tech titan HuaWei is a big deal and national champion for China. As China seeks to trudge on the long march toward tech supremacy, U.S. tech trade strategists should consider alternative approaches instead of the current legalistic approach to Sino-U.S. trade conflict resolution. It would be a symbolic loss of state dignity and sovereignty for China to agree to signing into law U.S. trade terms and conditions on intellectual property protection and enforcement. Alternatively, U.S. trade reps should focus on direct dispute negotiations between U.S. and Chinese tech corporations through the extant inland and international arbitration tribunals. This alternative mechanism may nevertheless favor domestic firms in China.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2023-02-07 08:26:00 Tuesday ET

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects. Michel De Vroey (2016)
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-09-05 09:26:00 Thursday ET

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America. Firs
2018-04-13 14:42:00 Friday ET

Mike Pompeo switches his critical role from CIA Director to State Secretary in a secret visit to North Korea with no regime change as the North Korean dicta
2020-09-11 10:22:00 Friday ET

AYA fintech network platform provides proprietary alpha stock signals and personal finance tools. In recent times, we have completed our fresh website up
2018-04-20 10:38:00 Friday ET

Allianz chairman Mohamed El-Erian bolsters a new American economic paradigm in lieu of the Washington consensus. The latter dominates the old school of thou